ATE210466T1 - Methoden zur behandlung von atemwegserkrankungen - Google Patents

Methoden zur behandlung von atemwegserkrankungen

Info

Publication number
ATE210466T1
ATE210466T1 AT96910597T AT96910597T ATE210466T1 AT E210466 T1 ATE210466 T1 AT E210466T1 AT 96910597 T AT96910597 T AT 96910597T AT 96910597 T AT96910597 T AT 96910597T AT E210466 T1 ATE210466 T1 AT E210466T1
Authority
AT
Austria
Prior art keywords
methods
treating respiratory
respiratory diseases
sinusitis
emphysema
Prior art date
Application number
AT96910597T
Other languages
English (en)
Inventor
John Mcmichael
Original Assignee
Milkhaus Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Milkhaus Lab Inc filed Critical Milkhaus Lab Inc
Application granted granted Critical
Publication of ATE210466T1 publication Critical patent/ATE210466T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96910597T 1995-04-13 1996-03-20 Methoden zur behandlung von atemwegserkrankungen ATE210466T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42123295A 1995-04-13 1995-04-13
PCT/US1996/004197 WO1996032138A1 (en) 1995-04-13 1996-03-20 Methods for treating respiratory disease

Publications (1)

Publication Number Publication Date
ATE210466T1 true ATE210466T1 (de) 2001-12-15

Family

ID=23669712

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96910597T ATE210466T1 (de) 1995-04-13 1996-03-20 Methoden zur behandlung von atemwegserkrankungen

Country Status (8)

Country Link
US (2) US5726160A (de)
EP (1) EP0766570B1 (de)
JP (1) JP2961709B2 (de)
AT (1) ATE210466T1 (de)
AU (1) AU716486B2 (de)
CA (1) CA2192674C (de)
DE (1) DE69617856T2 (de)
WO (1) WO1996032138A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7935675B1 (en) * 1994-07-15 2011-05-03 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6207646B1 (en) * 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US5948768A (en) * 1995-04-13 1999-09-07 Milkhaus Laboratory Treatment of otitis media by sublingual administration of DNA
US20030032614A1 (en) * 1995-04-13 2003-02-13 Mcmichael John Method of treating respiratory distress using synthetic polynucleic acids
US20020115632A1 (en) * 1995-04-13 2002-08-22 Milkhaus Laboratory, Inc. Treatment of symptoms of asthma and allergies
US6096721A (en) * 1995-04-13 2000-08-01 Milkhaus Laboratory, Inc. Method for treating mucositis by sublingual administration of DNA
AU716486B2 (en) * 1995-04-13 2000-02-24 Milkhaus Laboratory, Inc. Methods for treating respiratory disease
US6156780A (en) * 1996-10-17 2000-12-05 Milkhaus Laboratory, Inc. Treatment of fecal incontinence
US5877198A (en) * 1996-10-17 1999-03-02 Milkhaus Laboratory, Inc. Treatment of urinary incontinence
US6998121B2 (en) 2003-01-23 2006-02-14 Milkhaus Laboratory, Inc. Method of treatment of connective tissue disorders by administration of streptolysin O
EP1674574A1 (de) * 1998-05-14 2006-06-28 Coley Pharmaceutical GmbH Verfahren zur Regulierung der Hematopoiese mit Hilfe von CpG Oligonukleotide
US7585847B2 (en) * 2000-02-03 2009-09-08 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for the treatment of asthma and allergy
CA2502015A1 (en) * 2002-12-11 2004-06-24 Coley Pharmaceutical Group, Inc. 5' cpg nucleic acids and methods of use
US7629312B2 (en) 2003-01-23 2009-12-08 Milkhaus Laboratory, Inc. Method of treatment of tendonitis by administration of streptolysin O
US20100144602A1 (en) * 2003-01-23 2010-06-10 Milkhaus Laboratory, Inc. Methods of Inhibiting Metastatic Cancer by Administration of Streptolysin O
TWI235440B (en) * 2004-03-31 2005-07-01 Advanced Semiconductor Eng Method for making leadless semiconductor package
KR20080008350A (ko) * 2005-04-08 2008-01-23 콜레이 파마시티컬 그룹, 인코포레이티드 감염성 질환에 의해 악화된 천식의 치료 방법
WO2008094379A2 (en) * 2007-01-30 2008-08-07 Milkhaus Laboratory, Inc. Methods for treatment of pulmonary fibrosis
EP2819690A4 (de) 2012-02-27 2016-07-06 Beech Tree Labs Inc Verfahren zur behandlung der chronisch obstruktiven lungenkrankheit

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470838A (en) * 1987-10-28 1995-11-28 Pro-Neuron, Inc. Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
US5240846A (en) * 1989-08-22 1993-08-31 The Regents Of The University Of Michigan Gene therapy vector for cystic fibrosis
GB9027968D0 (en) * 1990-12-22 1991-02-13 Fisons Plc Method of treatment
EP0517573A1 (de) * 1991-06-05 1992-12-09 Synthelabo Pharmazeutische Zusammensetzungen zur Behandlung von Atemwegserkrankungen
US5292498A (en) * 1991-06-19 1994-03-08 The University Of North Carolina At Chapel Hill Method of treating lung disease with uridine triphosphates
WO1993012240A1 (en) * 1991-12-17 1993-06-24 The Regents Of The University Of California Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr)
JPH08511156A (ja) * 1993-04-06 1996-11-26 アメリカ合衆国 テナガザル白血球ウイルスベースのレトロウイルスベクター
DE4410188A1 (de) * 1994-03-24 1995-09-28 Boehringer Mannheim Gmbh Gentherapeutisches Verfahren unter Verwendung von antibiotikaresistenzgenfreien DNA-Vektoren
AU716486B2 (en) * 1995-04-13 2000-02-24 Milkhaus Laboratory, Inc. Methods for treating respiratory disease
US5635160A (en) * 1995-06-07 1997-06-03 The University Of North Carolina At Chapel Hill Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions
US5628984A (en) * 1995-07-31 1997-05-13 University Of North Carolina At Chapel Hill Method of detecting lung disease

Also Published As

Publication number Publication date
EP0766570B1 (de) 2001-12-12
EP0766570A4 (de) 1998-11-11
DE69617856D1 (de) 2002-01-24
WO1996032138A1 (en) 1996-10-17
JPH10500430A (ja) 1998-01-13
DE69617856T2 (de) 2002-06-27
EP0766570A1 (de) 1997-04-09
US5726160A (en) 1998-03-10
JP2961709B2 (ja) 1999-10-12
CA2192674C (en) 2001-02-13
AU5375196A (en) 1996-10-30
US5955442A (en) 1999-09-21
AU716486B2 (en) 2000-02-24

Similar Documents

Publication Publication Date Title
ATE210466T1 (de) Methoden zur behandlung von atemwegserkrankungen
EP0831848A4 (de) Verfahren zur behandlung von lungenkrankheiten unter verwendung von antisense-oligonukleotiden
FR2722506B1 (fr) Composition contenant des acides nucleiques, preparation et utilisations
ATE230439T1 (de) Gezielte gentherapie
BR9507506A (pt) Processo para exterminar uma célula processo para tratamento de càncer composição e kit terapéutico
DE60031456D1 (de) Rekombinante alpha-l-iduronisase, deren herstellungs- und aufreinigungsverfahren, und behandlung von durch diese hervorgerufene mangelerkrankungen
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
DE69625906D1 (de) Dinukleotide zur verwendung in der behandlung von lungenkrankheiten
DE69716255D1 (de) Verfahren zur behandlung von mittelohrentzündung mittels uridintriphosphaten und verwandten mitteln
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
MX9708854A (es) Terapia de genes para regulacion de celulas efectoras.
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
JP2005112863A (ja) 網膜の色素沈着された上皮由来の神経栄養性因子
ES2187648T3 (es) Metodo para la administracion de farmacos para terapia genica.
DE69934096D1 (de) Zusammensetzungen und methoden zur wundheilung
DE69510356D1 (de) Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie
DE69833876D1 (de) Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
CA2323213A1 (en) Treatment of respiratory disease and otitis media
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
BR9806912A (pt) Processos para liberar um ou mais ácidos nucleicos em neurÈnios motores de mamìferos, para produzir proteìna em neurÈnios motores de mamìferos, para induzir nós periféricos ou colaterais de extremidades de axÈnios motores, para proteger contra degeneração axÈnica, para tratar um dano ao sistema nervoso, e, para tratar esclerose lateral amiotrófica.
RU95100951A (ru) Способ лечения мужского бесплодия
ATE236630T1 (de) Verwendung von sklareolide für die behandlung von excessiven zellwachstumskrankheiten
DE69124382D1 (de) Authentischen igf-1 und hypokalorische menge von nährstoffen enthaltendes produkt und dessen verwendung zur behandlung kataboler zustände
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties